Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home

Did you not find what you were looking for? Try the Advanced Search to refine your search.

Search results 127 items matching your search terms

Subscribe to an always-updated feed of these search terms

European Community register of medicinal products for human use last modified 08 August 2006, 10:33 CET — filed under: — Relevance: 1%
EU Pharmaceutical Regulation: The Politics of Policy-making (European Policy Studies) (Amazon, Hardcover)
This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. It focuses on how the conflicting agendas of the ... last modified 25 September 2007, 15:06 CET — filed under: — Relevance: 1%
Forum assesses competitiveness of Europe's pharmaceutical industry
Europe's Pharmaceutical Forum has concluded its three-year process and, on 2 October, put forward several recommendations addressing the many challenges facing ... last modified 06 October 2008, 22:10 CET — filed under: — Relevance: 1%
Pharmaceutical Medicine, Biotechnology and European Law (Amazon, Hardcover)
European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of ... last modified 25 September 2007, 15:09 CET — filed under: — Relevance: 1%
Pharmaceutical products
This Statistics in Focus presents price level indices for pharmaceutical products for 33 European countries in 2005. Price levels vary between more than 80% ... last modified 07 May 2007, 13:40 CET — filed under: — Relevance: 1%
Pharmaceuticals in the EU
European Union action in the pharmaceutical products sector is basically composed of two types of measures relating to industrial policy and the smooth ... last modified 25 August 2006, 12:35 CET — filed under: — Relevance: 1%
Strengthening pharmacovigilance to reduce adverse effects of medicines - briefing
Medicinal products contribute considerably to the health of EU citizens. They can, however, also have adverse effects. It is estimated that 5% of all hospital ... last modified 11 December 2008, 00:13 CET — filed under: — Relevance: 1%
Information to patients on prescription-only medicinal products - briefing
Citizens of the European Union have become more empowered and proactive consumers of healthcare, increasingly seeking information about medicines and ... last modified 11 December 2008, 00:18 CET — filed under: — Relevance: 1%
Priorities for the Pharmaceutical sector in the EU
The pharmaceutical sector is extensively regulated by the European Union in the dual interest of protecting public health while completing the single market ... last modified 15 July 2009, 14:40 CET — filed under: — Relevance: 1%
On 15 January 2008 the European Commission launched an inquiry into competition in the pharmaceuticals sector. last modified 28 November 2008, 13:30 CET — filed under: , — Relevance: 1%
EU pharmaceutical sector inquiry - briefing
Market entry of generic drugs is delayed and there is a decline in the number of novel medicines reaching the market, according to the European Commission's ... last modified 08 July 2009, 23:10 CET — filed under: — Relevance: 1%
Preliminary EU report on pharmaceutical sector inquiry - briefing
The European Commission has published its preliminary report on the competition inquiry into the pharmaceutical sector, which finds that competition in this ... last modified 28 November 2008, 13:57 CET — filed under: , — Relevance: 1%
EU institutions strike deal on sustainable and flexible fee system
EU Council and European Parliament negotiators reached a provisional deal Monday on a regulation to modernise and simplify the structure of fees payable to the ... last modified 26 September 2023, 12:23 CET — filed under: , , — Relevance: 1%
Towards a stronger European response to drugs - EC Communication
The European Commission has given a fresh impetus to anti-drugs policy by announcing an overhaul of the EU rules to fight illicit drugs. last modified 26 October 2011, 14:16 CET — filed under: , , — Relevance: 1%
The European Medicines Agency is a decentralised body of the European Union, located in London. Its main responsibility is the protection and promotion of ... last modified 23 September 2010, 22:06 CET — filed under: , — Relevance: 1%
French Healthcare showcases its innovations at Medica & Compamed
A handpicked selection of French Healthcare companies will showcase their innovations and technologies at next week's Medica & Compamed. last modified 13 November 2020, 17:19 CET — filed under: , , — Relevance: 1%
EC measures to tackle biopiracy and facilitate nature-based research
Researchers and companies in the EU received a boost today with a new proposal that should provide reliable access to genetic resources from outside the Union. ... last modified 04 October 2012, 19:59 CET — filed under: , — Relevance: 1%
Search for pharmaceuticals companies in Europe
Chemicals and pharmaceuticals companies in Europe last modified 19 October 2010, 23:29 CET — filed under: — Relevance: 1%
Pharmaceuticals companies
Pharmaceuticals companies in Europe last modified 16 July 2014, 23:02 CET — filed under: — Relevance: 1%
Supplementary Protection Certificates - guide
The European Commission on 27 April proposed new rules to help companies, especially small and medium-sized companies (SMEs), make the most of their ... last modified 27 April 2023, 18:55 CET — filed under: , , — Relevance: 1%
Supplementary protection certificate for medicinal products
The EU Commission proposed on 28 May a targeted adjustment to intellectual property rules to help Europe's pharmaceutical companies tap into fast-growing ... last modified 29 May 2018, 23:34 CET — filed under: , — Relevance: 1%
The EU's move against innovation
As the European Commission prepares to publish its long-awaited review of pharmaceutical innovation incentives, two major factors must steer its future policy ... last modified 14 November 2017, 15:58 CET — filed under: , — Relevance: 1%
Revision of EU pharmaceutical legislation - guide
The European Commission proposed on 26 April to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, ... last modified 26 April 2023, 18:25 CET — filed under: , — Relevance: 1%
EU pharma legislation set for major reform
The Commission proposed Wednesday the largest reform of EU pharmaceutical legislation in over 20 years - with the aims of promoting innovation and ensuring ... last modified 27 April 2023, 21:42 CET — filed under: , , — Relevance: 1%
New psychoactive substances in Europe - an update from the EU Early Warning System (March 2015)
New psychoactive substances (NPS or ‘new drugs’) were detected in the European Union last year at the rate of around two per week, according to an update ... last modified 10 March 2015, 00:03 CET — filed under: , , — Relevance: 1%
European Drug Report 2017: Trends and Developments
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well ... last modified 07 June 2017, 00:11 CET — filed under: , — Relevance: 1%
Synthetic opioids a growing health threat: EU report
Highly potent synthetic opioids pose a growing health threat, according to an EU report Tuesday which highlights rising overdose deaths and continued ... last modified 07 June 2017, 18:38 CET — filed under: , , , — Relevance: 1%
European Drug Report 2013: Trends and developments
Europe’s drugs problem is in a ‘state of flux’, with new threats emerging that challenge current models of policy and practice. This is according to the ... last modified 28 May 2013, 17:32 CET — filed under: , , — Relevance: 1%
Pharma reform to tackle medicines shortages in EU
An EU Parliament committee adopted proposals Wednesday to revamp EU pharmaceutical legislation to foster innovation and enhance the security of supply, ... last modified 20 March 2024, 23:10 CET — filed under: , , , — Relevance: 1%
European Drug Report 2020: Trends and Developments
This report provides a comprehensive analysis of patterns emerging across Europe in the areas of drug supply, illicit drug use and associated public health ... last modified 22 September 2020, 21:49 CET — filed under: , , — Relevance: 1%
Weekly Diary

The Week Ahead no. 623
Waste framework directive - microplastic pollution - agriculture situation and Ukraine - Multilateral Investment Court

→ EUbusiness Week archive

Subscription options